NCT06772350View on ClinicalTrials.gov

Role of Altered Intestinal Permeability and Lipopolysaccharide in Thrombotic Risk and Vascular Injury in IBD Patients

NANot yet recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

June 15, 2025

Primary Completion Date

July 15, 2026

Study Completion Date

June 15, 2036

Conditions

IBD

Interventions

PROCEDURE

examinations

Echo-Doppler and blood samples

All Listed Sponsors

lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT06772350 - Role of Altered Intestinal Permeability and Lipopolysaccharide in Thrombotic Risk and Vascular Injury in IBD Patients | Biotech Hunter | Biotech Hunter